Revlimid and Laboratory test abnormal - a phase IV clinical study of FDA data

Summary:

Laboratory test abnormal is found among people who take Revlimid, especially for people who are 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Revlimid and have Laboratory test abnormal. It is created by eHealthMe based on reports of 331,128 people who have side effects when taking Revlimid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 02, 2023

331,128 people reported to have side effects when taking Revlimid.
Among them, 3,895 people (1.18%) have Laboratory test abnormal.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 331,426 Revlimid users for its effectiveness, alternative drugs and more.

What is Laboratory test abnormal?

Laboratory test abnormal is found to be associated with 2,406 drugs and 1,482 conditions by eHealthMe.

Number of Revlimid and Laboratory test abnormal reports submitted per year:

Could Revlimid cause Laboratory test abnormal?

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Laboratory test abnormal?

Check whether Laboratory test abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Laboratory test abnormal and when was it recovered:

Laboratory test abnormal in Revlimid

Expand to all the drugs that have ingredients of lenalidomide:

Laboratory test abnormal and drugs with ingredients of lenalidomide

Alternative drugs to, pros and cons of Revlimid:

Revlimid (331,426 reports)

Common Revlimid side effects:

Death: 24,344 reports
Diarrhea: 23,781 reports
Fatigue (feeling of tiredness): 21,089 reports
Multiple myeloma (cancer of the plasma cells): 17,070 reports
Pneumonia: 16,950 reports
Rashes (redness): 15,559 reports
Thrombocytopenia (decrease of platelets in blood): 14,033 reports
Weakness: 9,637 reports

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Laboratory test abnormal treatments and more:

Laboratory test abnormal (26,169 reports)

COVID vaccines that are related to Laboratory test abnormal:

Common drugs associated with Laboratory test abnormal:

All the drugs that are associated with Laboratory test abnormal:

Laboratory test abnormal (2,406 drugs)

Common conditions associated with Laboratory test abnormal:

All the conditions that are associated with Laboratory test abnormal:

Laboratory test abnormal (1,482 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.